Efficacy, safety, and predictors of response to infliximab therapy for ulcerative colitis: A <scp>K</scp>orean multicenter retrospective study

Abstract

Infliximab is effective and safe in the treatment of active UC in Korea. No history of previous immunomodulator use and high baseline C-reactive protein are independent predictors of good response.